RICHMOND, Calif., Jan. 4, 2019 /PRNewswire/ -- Sangamo Therapeutics, Inc. (NASDAQ: SGMO) announced today that Sandy Macrae, CEO of Sangamo, will present a corporate overview at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9th at 11:30 a.m. PT in San Francisco. Dr. Macrae's presentation will be followed by a separate Q&A session starting at 12:00 p.m. PT.
The presentation and Q&A session will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.
About Sangamo Therapeutics
Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic medicines with the potential to transform patients' lives using the Company's platform technologies in genome editing, gene therapy, gene regulation and cell therapy. For more information about Sangamo, visit www.sangamo.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-to-present-at-the-37th-annual-jp-morgan-healthcare-conference-300772882.html
SOURCE Sangamo Therapeutics, Inc.
Investors: McDavid Stilwell, 510-970-6000, x219, mstilwell@sangamo.com; Varant Shirvanian, 510-970-6000 x205, vshirvanian@sangamo.com; Media Inquiries - United States: Aron Feingold, 510-970-6000, x421, afeingold@sangamo.com; Investor Relations and Media Inquiries - European Union: Caroline Courme, 33 4 97 21 27 27, ccourme@sangamo.com
